Training for Academic Hematology

学术血液学培训

• 批准号: 8077323
• 负责人: VICTOR JACK MARDER
• 金额: $ 19.4万
• 依托单位: UNIVERSITY OF CALIFORNIA LOS ANGELES
• 依托单位国家: 美国
• 财政年份: 2002
• 资助国家: 美国
• 起止时间: 2002-07-01 至 2012-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8077323
• 关键词: Academic Training; Hematology

DESCRIPTION (provided by applicant): This application is for competitive renewal of a PHS Institutional National Service Award at the David Geffen School of Medicine at UCLA to prepare fellows for an academic career in Hematology. This award was initiated in July, 2002, and supports 4 fellowship slots in years 2 and 3 of Hematology/Medical Oncology training. Of 11 fellows who have entered the program, 4 are currently in training and 7 have completed their fellowship, of which 4 are on the full-time faculty at UCLA, two are in clinical trial development with industry, and one has entered clinical practice. The faculty consists of 31 academic scientists and physicians, grouped into four areas of mutual research interest, Hematopoiesis and Stem Cell Biology (Kenneth Dorshkind, PhD, Director), Leukemia (Gary Schiller, MD, Director), Lymphocyte Biology and Lymphoma (Alan Lichtenstein, MD, Director) and Hemostasis, Thrombosis and Vascular Biology (Victor Marder, MD, Director). The entire faculty have extramural research grant support, including 24 (77%) with NIH grants. Interaction with other training programs in complementary disciplines emphasizes our goal of interactive basic and translational research careers. A research retreat is; held each spring, during which time each mentor presents an overview of the laboratories' research interest, followed by a report of the respective fellows' progress. Formal review of the mentor's effectiveness and the fellow's progress and goals are prepared by the Steering Committee, made up of the four Focus Directors. A core curriculum is offered to all fellows, including a "Clinical Research Course", which covers subjects on research design and analysis, ethics, regulatory, issues, grant preparation and responsible conduct of research. Fellows are encouraged to obtain an advanced degree as part of the STAR program, with formal course work in appropriate departments for one or two additional years. Of the 7 fellows who have completed their program during the interval 2002 - present, 2 have obtained the Master's degree and 1 has received a PhD degree. The training of hematologists with expertise in basic, clinical and translational research is an important priority for the David Geffen School of Medicine at UCLA and this application seeks support for the pivotal period between clinical training and an eventual career in academic hematology.

描述（由申请人提供）： 此申请旨在竞争性更新加州大学洛杉矶分校大卫格芬医学院的 PHS 机构国家服务奖，为研究员在血液学领域的学术生涯做好准备。该奖项于 2002 年 7 月启动，支持血液学/肿瘤内科培训第 2 年和第 3 年的 4 个奖学金名额。在已进入该项目的 11 名研究员中，4 名目前正在接受培训，7 名已完成研究员身份，其中 4 名是加州大学洛杉矶分校的全职教师，两名正在与业界一起进行临床试验开发，一名已进入临床实践。该学院由 31 名学术科学家和医生组成，分为四个共同研究兴趣领域：造血和干细胞生物学（Kenneth Dorshkind，博士，主任）、白血病（Gary Schiller，医学博士，主任）、淋巴细胞生物学和淋巴瘤（Alan Lichtenstein） ，医学博士，主任）和止血、血栓形成和血管生物学（Victor Marder，医学博士，主任）。全体教职员工均获得校外研究资助，其中 24 名（77%）获得 NIH 资助。与互补学科中其他培训项目的互动强调了我们互动基础和转化研究职业的目标。研究静修是；每年春季举行，在此期间，每位导师都会概述实验室的研究兴趣，然后报告各自研究员的进展。由四位焦点主任组成的指导委员会负责对导师的有效性以及研究员的进展和目标进行正式审查。为所有研究员提供核心课程，包括“临床研究课程”，涵盖研究设计和分析、伦理、监管、问题、拨款准备和负责任的研究行为等主题。作为 STAR 计划的一部分，鼓励研究员获得高级学位，并在适当的部门继续学习一到两年的正式课程。 2002年至今完成学业的7名研究员中，2人获得硕士学位，1人获得博士学位。培养具有基础、临床和转化研究专业知识的血液学家是加州大学洛杉矶分校大卫格芬医学院的一个重要优先事项，该申请旨在为临床培训和最终从事学术血液学职业之间的关键时期寻求支持。